Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.

doi:10.1016/0014-2999(83)90212-1

Paper

DOI: 10.1016/0014-2999(83)90212-1

Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.

Published May 20, 1983 · J. Arnt

European journal of pharmacology

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Study Snapshot

Antagonism of 6,7-ADTN-induced hyperactivity is a relevant model for detecting neuroleptic activity, with minimal influence from anticholinergic and antiserotonergic activity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1111/J.1600-0773.1982.TB00934.X

Functional importance of nucleus accumbens noradrenaline in the rat.

L-noradrenaline is more potent than d-noradrenaline in suppressing ambulatory activity and increasing activity in rats, with d-noradrenaline having less efficient effects.

2009·27citations·L. Svensson et al.·Acta pharmacologica et toxicologica

Acta pharmacologica et toxicologica

DOI: 10.1111/J.1600-0773.1978.TB02191.X

Neuroleptic blockade of the effect of various neurotransmitter substances.

Neuroleptics exhibit different profiles in their interaction with various neurotransmitter substances, with some showing potent anti-5HT and antihistamine effects, potentially contributing to their central effects.

2009·24citations·B. Fjalland et al.·Acta pharmacologica et toxicologica

Acta pharmacologica et toxicologica

DOI: 10.1021/JM00361A002

Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.

1-piperazino-3-phenylindans show neuroleptic activity and dopamine-uptake inhibition, with the most potent compounds being 1-piperazino-3-(3,4-dichlorophenyl)indans with IC50 values of about 2nM.

1983·40citations·Böge Kp·Journal of Medicinal Chemistry

Journal of Medicinal Chemistry

DOI: 10.1016/0014-2999(81)90365-4

Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.

DB-6,7-ADTN induces hypomotility in animals, which can be attenuated by dopamine receptor antagonists and alpha-adrenergic blockers.

1981·20citations·C. Sumners et al.·European journal of pharmacology

European journal of pharmacology

DOI: 10.1016/0024-3205(81)90314-3

Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP.

GABAergic control inhibits both glutamate and dopamine systems, influencing locomotor activity in rats.

1981·48citations·J. Arnt·Life sciences

Life sciences

DOI: 10.1016/0014-2999(81)90608-7

Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.

Scopolamine reverses neuroleptic-induced catalepsy and amphetamine-induced stereotypies in rats, with butyrophenones being more sensitive to scopolamine reversal.

1981·43citations·J. Arnt et al.·European journal of pharmacology

European journal of pharmacology

DOI: 10.1176/AJP.137.12.1518

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

Neuroleptic clinical potency is closely linked to their affinity for dopamine receptors, while substantial occupancy of serotonin, alpha-adrenergic, and histamine receptors often occurs at effective doses.

1980·533citations·S. Peroutka et al.·The American journal of psychiatry

The American journal of psychiatry

DOI: 10.1016/0166-2236(79)90041-9

Schizophrenia and dopamine regulation in the mesolimbic system

The ventral tegmental area in the brainstem serves as a crucial dopaminergic 'crossroad' with implications for various neural functions, including neuroendocrine control and schizophrenia.

1979·91citations·J. Stevens·Trends in Neurosciences

Trends in Neurosciences

Citations

DOI: 10.1007/7854_2016_447

Preclinical Effects of Antipsychotic Drugs.

Antipsychotic drugs effectively reduce positive symptoms of schizophrenia, but cause significant side effects, with clozapine being effective in therapy-resistant patients.

2016·5citations·Jenny Sanchez et al.·Current topics in behavioral neurosciences

Current topics in behavioral neurosciences

DOI: 10.1111/J.1600-0773.1984.TB01996.X

The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.

Citalopram/5-HTP-induced head shake syndrome is most sensitive to 5-HT2 antagonists, but also influenced by other neuronal systems.

2009·69citations·J. Arnt et al.·Acta pharmacologica et toxicologica

Acta pharmacologica et toxicologica

DOI: 10.1016/0014-2999(95)00292-S

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.

Classical antipsychotics and dopamine D2 receptor antagonists inhibit hypermotility at both low and high D-amphetamine doses, while newer antipsychotics preferentially inhibit the low dose, highlighting different neuronal interactions.

1995·137citations·J. Arnt·European journal of pharmacology

European journal of pharmacology

DOI: 10.1016/0014-2999(93)90557-X

Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics.

Atypical and typical neuroleptics alter subcortical excitatory amino acid levels in a site-specific manner, with clozapine, sulpiride, and ()-3-PPP showing different effects in the nucleus accumbens and corpus striatum.

1993·35citations·M. Bardgett et al.·European journal of pharmacology

European journal of pharmacology

DOI: 10.1016/0091-3057(92)90079-U

Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists

Intra-accumbens injections of dopamine agonists and antagonists can control locomotor activity direction, suggesting a bilateral dopamine organization in the mesolimbic dopamine system.

1992·22citations·C. Messier et al.·Pharmacology Biochemistry and Behavior

Pharmacology Biochemistry and Behavior